Dr. Paula Cramer - Mapping the Pathways to Long-Term Treatment Benefit in Chronic Lymphocytic Leukemia (CLL): Strategies for Aligning Patient Priorities With Evidence for Initiating and Sequencing Targeted Therapy
Associate Professor Jim Whittle, MBBS, PhD, FRACP / Katie Metrock, MD - Moving MEK Inhibitor Therapy FORWARD in NF1: A Neuro-Oncology FOrum on Real-World Application of Recent Data for Improving Patient Care
Hussein A. Tawbi, MD, PhD - New Rules for Sequential Care in BRAF-Mutated Melanoma: Rethinking Upfront Selection and Sequencing of Immunotherapy and Targeted Agents in Metastatic Disease
PeerView Immunology & Transplantation CME/CNE/CPE Audio PodcastMichael Heinrich, MD - Optimally Sequencing Modern TKIs in GIST: Expert Perspectives From an Interprofessional Sarcoma Team
PeerView Internal Medicine CME/CNE/CPE Audio PodcastAnthony R. Mato, MD, MSCE - The Next Building Block for B-Cell Cancer Care: Exploring Personalized Treatment With Emerging BTK Inhibitor Options in CLL/SLL and MCL
PeerView Internal Medicine CME/CNE/CPE Audio PodcastMelissa L. Johnson, MD - Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC
PeerView Internal Medicine CME/CNE/CPE Audio Podcast